BioRestorative Therapies Inc expected to post a loss of 69 cents a share - Earnings Preview

Biorestorative Therapies

29/03/2024 21:13

* BioRestorative Therapies Inc  BRTX.OQ   BRTX.O  is
expected
to show a rise in quarterly revenue when it reports  results on
April 1 (estimated) for the period ending December 31 2023
    * The Melville New York-based  company is expected to report
a
275.0% increase in revenue to $15 thousand from $4 thousand a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for BioRestorative Therapies
Inc
is for a loss of 69 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
BioRestorative
Therapies Inc is $12.50​, above​ its last closing price
of $1.38. ​​​

This summary was machine generated March 29 at 21:13 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)